Elon Musk reveals Neuralink Blindsight device — cortical visual prosthesis for the blind
Summary
Elon Musk announced Neuralink's second product — Blindsight — a cortical visual prosthesis targeting individuals who have lost vision due to optic nerve or retinal damage. The device uses a high-density electrode array placed on the visual cortex to deliver phosphene patterns representing a camera feed. Musk claimed resolution exceeding current retinal implants, with first human implant targeting 2025.
Why it matters
Blindsight entering development alongside the N1 motor BCI signals Neuralink's intent to become a platform company across multiple neural interface indications. Cortical visual prostheses have been a research goal for 50 years — Neuralink's manufacturing scale and regulatory momentum could finally bring it to clinical reality.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial